CurrentEndo coverage · page 31 of 55

Diabetes, Obesity and Metabolism

Briefs 1,201–1,240 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab27 Feb 2025
Impact of a 12‐week personalized dietary intervention on vascular function and cardiovascular risk factors
Secondary analysisObesity
Diabetes Obes Metab27 Feb 2025
Machine learning approach on plasma proteomics identifies signatures associated with obesity in the KORA FF4 cohort
Cross-sectional studyObesity
Diabetes Obes Metab26 Feb 2025
Estimating healthcare resource utilisation and cardiovascular events in people with high body mass index and established cardiovascular disease
Cohort studyObesity
Diabetes Obes Metab25 Feb 2025
Most hospitalised patients with type 2 diabetes benefit from continuous glucose monitoring compared to point‐of‐care glucose testing in a non‐intensive care unit setting: A heterogeneity of treatment effect analysis
Secondary analysisTechnology
Diabetes Obes Metab25 Feb 2025
A comparison of ultra‐rapid and rapid insulin in automated insulin delivery for type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
Meta-analysisTechnology
Diabetes Obes Metab25 Feb 2025
Association of depression, traditional risk factor control and genetic risk with incident cardiovascular disease among individuals with prediabetes: A population‐based prospective study from UK biobank
Cohort studyT2D & other
Diabetes Obes Metab25 Feb 2025
Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
Cohort studyT2D & other
Diabetes Obes Metab25 Feb 2025
Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight
Secondary analysisObesity
Diabetes Obes Metab25 Feb 2025
External validation of a prediction model for estimating fat mass in Arab children and adolescents
Diagnostic or prognostic studyObesity
Diabetes Obes Metab25 Feb 2025
Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets
Cohort studyT2D & other
Diabetes Obes Metab25 Feb 2025
Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery
Mechanistic studyObesity
Diabetes Obes Metab25 Feb 2025
Real‐world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database
Cohort studyObesity
Diabetes Obes Metab20 Feb 2025
Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis
Meta-analysisComplications
Diabetes Obes Metab19 Feb 2025
Efficacy and safety of a bio ‐absorbable antibiotic delivery in calcium sulphate granules for the treatment of osteomyelitis in patients with diabetic foot: A randomized, double blinded, controlled clinical study The BIG D‐ FOOT study
Randomized controlled trialComplications
Diabetes Obes Metab19 Feb 2025
Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol
Trial designT2D & other
Diabetes Obes Metab19 Feb 2025
Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
Cohort study
Diabetes Obes Metab19 Feb 2025
Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study
Cohort studyObesity
Diabetes Obes Metab19 Feb 2025
Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type‐2 diabetes and chronic kidney disease: DPV registry study
Cross-sectional studyT2D & other
Diabetes Obes Metab18 Feb 2025
Temporal risk patterns of severe hypovolemia associated with sodium‐glucose cotransporter‐2 inhibitors in patients with type 2 diabetes mellitus: A self‐controlled case series study
Cohort studyT2D & other
Diabetes Obes Metab18 Feb 2025
Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021
Secondary analysisObesity
Diabetes Obes Metab17 Feb 2025
Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
Research article
Diabetes Obes Metab14 Feb 2025
Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin‐naive adults with suboptimally controlled type 2 diabetes
Secondary analysisT2D & other
Diabetes Obes Metab14 Feb 2025
Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab14 Feb 2025
Alternative dosing regimens of GLP ‐1 receptor agonists may reduce costs and maintain weight loss efficacy
Research articleObesity
Diabetes Obes Metab14 Feb 2025
Fixed dose combination of dapagliflozin, glimepiride and extended‐release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III , open label, randomized clinical study in India
Randomized controlled trialT2D & other
Diabetes Obes Metab14 Feb 2025
Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks
Cohort studyObesity
Diabetes Obes Metab13 Feb 2025
Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
Cross-sectional studyT1D
Diabetes Obes Metab11 Feb 2025
A DiRECT approach to weight loss in a culturally diverse, low‐income population: Pilot randomised controlled trial and meta‐analysis of similar interventions
Meta-analysisT2D & other
Diabetes Obes Metab11 Feb 2025
Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial
Randomized controlled trialComplications
Diabetes Obes Metab11 Feb 2025
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial
Randomized controlled trialT2D & other
Diabetes Obes Metab10 Feb 2025
Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
Secondary analysisTechnology
Diabetes Obes Metab10 Feb 2025
Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
Secondary analysisT2D & other
Diabetes Obes Metab10 Feb 2025
Adding social determinants of health to the equation: Development of a cardiometabolic disease staging model using clinical and social determinants of health to predict type 2 diabetes
Diagnostic or prognostic studyT2D & other
Diabetes Obes Metab10 Feb 2025
Annual prevalence and factors associated with body mass index documentation in German general practices—A retrospective cross‐sectional study
Cross-sectional study
Diabetes Obes Metab10 Feb 2025
Characterization of the effect of naltrexone/bupropion on body composition
Secondary analysisObesity
Diabetes Obes Metab10 Feb 2025
GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
Cohort studyObesity
Diabetes Obes Metab10 Feb 2025
Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
Cohort studyT2D & other
Diabetes Obes Metab6 Feb 2025
Association of metabolic dysfunction‐associated fatty liver disease with white matter hyperintensity and cognitive decline: A longitudinal cohort study
Cohort studyLipids & liver
Diabetes Obes Metab5 Feb 2025
Comparison of the efficacy and safety of GLP ‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab5 Feb 2025
Efficacy of high‐intensity interval training in individuals with type 2 diabetes mellitus: An umbrella review of systematic reviews and meta‐analyses
Meta-analysisT2D & other

All 2,200 Briefs in ExploreShowing Briefs 1,201–1,240 of 2,200, newest first